Literature DB >> 4140327

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

J U Gutterman, E M Hersh, V Rodriguez, K B McCredie, G Mavligit, R Reed, M A Burgess, T Smith, E Gehan, G P Bodey, E J Freireich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4140327     DOI: 10.1016/s0140-6736(74)90070-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Editorial: BCG in cancer.

Authors: 
Journal:  Br Med J       Date:  1976-06-19

2.  Prolonged remission maintenance in acute myeloid leukaemia.

Authors:  A S Spiers; J M Goldman; D Catovsky; C Costello; D A Galton; C S Pitcher
Journal:  Br Med J       Date:  1977-08-27

3.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

4.  BCG and cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

5.  Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.

Authors:  J U Gutterman; J O Cardenas; G R Blumenschein; G Hortobagyi; M A Burgess; R B Livingston; G M Mavligit; E J Freireich; J A Gottlieb; E M Hersh
Journal:  Br Med J       Date:  1976-11-20

6.  Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial.

Authors:  T Ochiai; H Sato; R Hayashi; T Asano; H Sato; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation.

Authors:  R Ohno; K Yamada; T Masaoka; T Ohshima; I Amaki; Y Hirota; N Horikoshi; A Horiuchi; K Imai; I Kimura
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.

Authors:  H Rühl; H H Fülle; K M Koeppen; R Schwerdtfeger
Journal:  Klin Wochenschr       Date:  1981-11-02

9.  Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.

Authors:  P B McCulloch; P B Dent; M Blajchman; W M Muirhead; R A Price
Journal:  Can Med Assoc J       Date:  1977-07-09       Impact factor: 8.262

10.  Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.

Authors:  D Urbanitz; T Büchner; H Pielken; J van de Loo
Journal:  Klin Wochenschr       Date:  1983-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.